Michael J. Sofia, Ph.D.

Michael J. Sofia, Ph.D.

Former Chief Scientific OfficeratArbutus Biopharma· In proxies 2022–2024

Pay in FY2024Arbutus Biopharma stock +30.8% the same year

Michael J. Sofia, Ph.D. was paid $1.8M in FY2024 (Dec). Arbutus Biopharma stock rose 30.8% that year.

Pay$100 in the stock at the end of FY21 → $78
Pay is from the Summary Compensation Table of each Arbutus Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Arbutus BiopharmaPublic company · 4 yr
    • Former Chief Scientific Officer2022 – Present · 4 yrStock in role +12%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?